Clinically relevant treatment considerations regarding lithium use in bipolar disorder

References

• Lange C. On periodical depressions and their pathogenesis. Hist Psychiatry. 2011;22(85 Pt 1):108–130.
   PubMed Web of Science ®Google Scholar
• Rosen M. Lithium in child and adolescent bipolar disorder. Am J Psychiatry Residents’ J. 2017;12(2):3–5.
   Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. April 2002. Available at http://psychiatryonline.org [Last Accessed 2017 Apr 25]
   Google Scholar
• National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. September 2014. [cited 2017 Aug 12]. Available from: http://nice.org.uk/guidance/cg185
   Google Scholar
• Fountoulakis KN, Yatham L, Grunze H, et al. The international college of neuro-psychopharmacology treatment guidelines for bipolar disorder in adults, part 2: review, grading of the evidence, and a precise algorithm. Int J Neuropsychopharmacol. 2017;20(2):121–179.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Adams D, Berk M. Is lithium in a class of its own? A brief profile of its clinical use. Aust N Z J Psychiatry. 2009;43(12):1096–1104.
   PubMed Web of Science ®Google Scholar
• Schou M. Serum lithium monitoring of prophylactic treatment: critical review and updated recommendations. Clin Pharmacokinet. 1988;15(5):283–286.
   PubMed Web of Science ®Google Scholar
• Kapusta ND, Mossaheb N, Etzersdorfer E, et al. Lithium in drinking water and suicide mortality. Br J Psychiatry. 2011;198(5):346–350.
   PubMed Web of Science ®Google Scholar
• Vita A, De Peri L, Sacchetti E. Lithium in drinking water and suicide prevention: a review of the evidence. Int Clin Psychopharmacol. 2015;30(1):1–5.
   PubMed Web of Science ®Google Scholar
• Vo TM, Perry P, Ellerby M, et al. Is lithium a neuroprotective agent? Ann Clin Psychiatry. 2015;27(1):49–54.
   PubMed Web of Science ®Google Scholar
• Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry. 2015;20(6):661–670.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Forgione B, Maccari C, et al. Prevalence, chronicity, burden and borders of bipolar disorder. J Affect Disord. 2013;148(2–3):161–169.
   PubMed Web of Science ®Google Scholar
• Lembke A. Optimal dosing of lithium, valproic acid, and lamotrigine in the treatment of mood disorders. Primary Psychiatry. 2009;16(10):37–42.
   Google Scholar
• Eskalith (lithium carbonate) prescribing information. GlaxoSmithKline. 2003. [cited 2016 Oct 25]. Available from: http://www.accessdata.fda.gov
   Google Scholar
• Finley PR. Drug interactions with lithium: an update. Clin Pharmacokinet. 2016;55(8):925–941.
   PubMed Web of Science ®Google Scholar
• Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4(1):27.
   PubMed Web of Science ®Google Scholar
• Stahl S. Essential Psychopharmacology, Prescriber’s Guide. 5th ed. New York, NY: Cambridge University Press; 2014.
   Google Scholar
• Permoda-Osip A, Abramowicz M, Kraszewska A, et al. Kidney, thyroid and other organ functions after 40 years or more of lithium therapy: a case series of five patients. Ther Adv Psychopharmacol. 2016;6(4):277–282.
   PubMed Web of Science ®Google Scholar
• Williams D Lithium toxicity: risk factors, monitoring, and management. U.S. Pharmacist, 2014. [cited 2016 Oct 25]. Available from: https://www.uspharmacist.com/ce/lithium-toxicity-risk-factors-monitoring.
   Google Scholar
• Joffee RT. How should lithium-induced thyroid dysfunction be managed in patients with bipolar disorder? J Psychiatry Neurosci. 2002;27(5):392.
   Web of Science ®Google Scholar
• Danielyan A, Kowatch RA. Management options for bipolar disorder in children and adolescents. Paediatr Drugs. 2005;7(5):277–294.
   PubMedGoogle Scholar
• Diav-Citrin O, Shechtman S, Tahover E, et al. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry. 2014;171(7):785–794.
   PubMed Web of Science ®Google Scholar
• Lithobid (lithium carbonate USP) prescribing information. ANI Pharmaceuticals, Inc. 2016. [cited 2016 Oct 25]. Available from: http://www.accessdata.fda.gov
   Google Scholar
• Crabtree BL, Mack JE, Johnson CD, et al. Comparison of the effects of hydrochlorothiazide and furosemide on lithium disposition. Am J Psychiatry. 1991;148(8):1060–1063.
   PubMed Web of Science ®Google Scholar
• Saffer D, Coppen A. Furosemide: a safe diuretic during lithium therapy? J Affec Disord. 1983;5(4):289–292.
   PubMed Web of Science ®Google Scholar
• Finley PR, O’Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol. 1996;16(1):68–71.
   PubMed Web of Science ®Google Scholar
• Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry. 2003;64(11):1328–1334.
   PubMed Web of Science ®Google Scholar
• Schatzberg A, Nemeroff C, editors. The American psychiatric publishing textbook of psychopharmacology. 4th ed. Arlington, VA: American Psychiatric Publishing, Inc.; 2009.
   Google Scholar
• Carson SW. Lithium. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics: principles of therapeutic drug monitoring. 3rd. Chap 34. Vancouver, WA: Applied Therapeutics. 1992.
   Google Scholar
• Gai MN, Thielemann AM, Arancibia A. Effect of three different diets on the bioavailability of a sustained release lithium carbonate matrix tablet. Int J Clin Pharmacol Ther. 2000;38(6):320–326.
   PubMed Web of Science ®Google Scholar
• Kishore BK, Ecelbarger CM. Lithium: a versatile tool for understanding renal physiology. Am J Physiol Renal Physiol. 2013;304(9):F1139–49.
   PubMed Web of Science ®Google Scholar
• Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16(3):165–177.
   PubMed Web of Science ®Google Scholar
• Singh LK, Nizamie SH, Akhtar S, et al. Improving tolerability of lithium with a once-daily dosing schedule. Am J Ther. 2011;18(4):288–291.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Dmitrzak-Weglar M, Kliwicki S, et al. Polymorphism of circadian clock genes and prophylactic lithium response. Bipolar Disord. 2014;16(2):151–158.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. CNS Drugs. 2013;27(3):165–173.
   PubMed Web of Science ®Google Scholar
• Chen CK, Lee CS, Chen HY, et al. GADL1 variant and medication adherence in predicting response to lithium maintenance treatment in bipolar I disorder. BJPsych Open. 2016;2(5):301–306.
   PubMed Web of Science ®Google Scholar
• Hou L, Heilbronner U, Degenhardt F, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387:1085–1093.
   PubMed Web of Science ®Google Scholar
• Price LH, Heninger GR. Lithium in the treatment of mood disorders. N Engl J Med. 1994;331(9):591–598.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Tanious M, Das P, et al. Potential mechanisms of action of lithium in bipolar disorder: current understanding. CNS Drugs. 2013;27(2):135–153.
   PubMed Web of Science ®Google Scholar
• Severus E, Taylor MJ, Sauer C, et al. Lithum for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2:15.
   PubMedGoogle Scholar
• Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: part I: clinical efficacy in bipolar disorder. CNS Drugs. 2009;23(3):225–240.
   PubMed Web of Science ®Google Scholar
• Vazquez GH, Holtzmann JN, Tondo L, et al. Efficacy and tolerability of treatments for bipolar depression. J Affect Disord. 2015;183:258–262.
   PubMed Web of Science ®Google Scholar
• Royahemi J, Bayle JF, Richa S. Predictors of prophylactic response to lithium. Encephale. 2008;34(4):394–399.
   PubMed Web of Science ®Google Scholar
• Bauer M, Adli M, Bschor T, et al. Lithium’s emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Neuropsychobiology. 2010;62(1):36–42.
   PubMed Web of Science ®Google Scholar
• Lewitzka U, Severus E, Bauer R, et al. The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review. Int J Bipolar Disord. 2015;3(1):32.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495–553.
   PubMed Web of Science ®Google Scholar
• Pompili M, Gonda X, Serafini G, et al. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 2013;15(5):457–490.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006;8(5 Pt 2):625–639.
   PubMed Web of Science ®Google Scholar